UBE2L6

Chr 11

ubiquitin conjugating enzyme E2 L6

Also known as: RIG-B, UBCH8

The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination involves at least three classes of enzymes: ubiquitin-activating enzymes (E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin-protein ligases (E3s). This gene encodes a member of the E2 ubiquitin-conjugating enzyme family. This enzyme is highly similar in primary structure to the enzyme encoded by the UBE2L3 gene. Two alternatively spliced transcript variants encoding distinct isoforms have been found for this gene. [provided by RefSeq, May 2011]

OMIMResearchGenerating clinical summary…
0
Active trials
26
Pubs (1 yr)
—
P/LP submissions
—
P/LP missense
1.34
LOEUF
Multiple*
Mechanism· predicted

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.34LOEUF
pLI 0.008
Z-score 0.99
OE 0.59 (0.29–1.34)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.54Z-score
OE missense 0.84 (0.71–1.01)
82 obs / 97.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.59 (0.29–1.34)
0≤0.351.4
Missense OE?0.84 (0.71–1.01)
0≤0.61.4
Synonymous OE?0.96
0≤1.21.6
LoF obs/exp: 4 / 6.8Missense obs/exp: 82 / 97.1Syn Z: 0.23

ClinVar Variant Classifications

0 submitted variants in ClinVar

Protein Context — Lollipop Plot

UBE2L6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →